1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The Valbenazine API market is evolving rapidly, shaped by changing regulatory demands, emerging technologies, and complex global dynamics. Senior executives face increased pressure to future-proof strategies as innovation and compliance requirements redefine global supply networks.
Market Snapshot
Valbenazine API represents a major advance in the treatment of movement disorders, notably tardive dyskinesia, with its adoption accelerated by specialist endorsement and regulatory approvals. Recent transformative shifts stem from patent expirations, increased generic entrants, and dynamic regulatory environments. The aging global population coupled with higher demand for specialized neuropharmaceuticals amplifies the need for robust manufacturing, process optimization, and resilient sourcing models, all while meeting stringent quality and sustainability standards.
Scope & Segmentation
This report offers an in-depth view into the Valbenazine API landscape, covering technology, regional, and operational factors critical for B2B decision-makers. Segmentation includes the full market value chain, from chemistry-driven synthesis to final distribution.
- Distribution Channels: Hospital Pharmacy, Retail Pharmacy, Specialty Pharmacy
- Dosage Strengths: 40 mg, 80 mg
- Treatment Settings: Inpatient, Outpatient
- Patient Age Groups: Adults 18–40, Adults 41–64, Elderly 65+
- Gender: Male, Female
- Regions: Americas (including key U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, Saudi Arabia, others), Asia-Pacific (including China, India, Japan, South Korea, Australia, and Southeast Asia)
- Key Industry Players: Lonza Group AG, Thermo Fisher Scientific Inc., Catalent Inc., WuXi AppTec Co. Ltd., Recipharm AB, Jubilant Life Sciences, Cambrex Corporation, Siegfried Holding AG, Piramal Pharma, Almac Group Limited
- Technological Innovations: Continuous flow chemistry, process intensification, digital twins, green solvents, advanced impurity profiling
Key Takeaways
- Selective VMAT2 inhibition positions Valbenazine API as a driver for new treatment paradigms, and sparks advanced research into derivatives and novel delivery systems.
- Manufacturers must respond to tougher impurity thresholds and evolving pharmacopoeial standards by investing in next-generation analytics and flexible validation models.
- Digitalization—using predictive maintenance, real-time analytics, and integrated management systems—now underpins operational agility and compliance monitoring.
- Collaborative partnerships between pharmaceutical firms, academic institutions, and technology providers accelerate process innovation and scalable manufacturing capacity.
- Multi-site and hybrid manufacturing models, paired with diversified sourcing, reduce vulnerability to regulatory shifts and supply disruption.
- Robust segmentation—covering channel, dosage, treatment environment, and patient demographics—enables tailored inventory planning and more precise regulatory submissions.
Tariff Impact
The 2025 United States tariff adjustments directly affect Valbenazine API supply chains by raising costs on core precursor chemicals and extending lead times. Manufacturers face increased customs complexity and compliance costs, as well as heightened need for supplier diversification and risk mitigation. Strategic responses range from qualifying alternate international suppliers to developing in-house synthesis, enabling companies to safeguard against sudden supply interruptions.
Methodology & Data Sources
Report insights derive from a robust mixed-method approach, combining extensive primary interviews with executives, chemists, and regulatory specialists, as well as desk research covering regulatory documents, pharmacopeia, and patent literature. Additional validation involved expert workshops and triangulation of market data using quantitative and qualitative analytic techniques.
Why This Report Matters
- Enables executive teams to proactively align sourcing, capacity planning, and compliance practices amid regulatory flux.
- Equips manufacturers and supply chain leaders with actionable insights for competitive positioning and risk management in the Valbenazine API sector.
- Helps stakeholders anticipate regional and technological developments to inform investment and partnership strategies.
Conclusion
As innovation, compliance, and operational agility reshape the Valbenazine API marketplace, organizations that integrate digital technologies, collaborative research, and adaptive sourcing models will realize lasting strategic advantage. Informed planning and responsive execution remain paramount for capturing value and ensuring supply continuity in this evolving field.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of contract manufacturing organizations capacity for Valbenazine API due to rising tardive dyskinesia cases
5.2. Strategic partnerships between API producers and specialty pharma companies to secure Valbenazine supply
5.3. Impact of upcoming Valbenazine API patent expiry on generic manufacturer entry and pricing dynamics
5.4. Regulatory harmonization efforts influencing Valbenazine API export approvals across major markets
5.5. Biotech investments accelerating process optimization technologies for Valbenazine API synthesis
5.6. Growing demand for high-purity Valbenazine API amid stricter quality standards in neuropharmacology
5.2. Strategic partnerships between API producers and specialty pharma companies to secure Valbenazine supply
5.3. Impact of upcoming Valbenazine API patent expiry on generic manufacturer entry and pricing dynamics
5.4. Regulatory harmonization efforts influencing Valbenazine API export approvals across major markets
5.5. Biotech investments accelerating process optimization technologies for Valbenazine API synthesis
5.6. Growing demand for high-purity Valbenazine API amid stricter quality standards in neuropharmacology
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Valbenazine API Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Retail Pharmacy
8.4. Specialty Pharmacy
8.2. Hospital Pharmacy
8.3. Retail Pharmacy
8.4. Specialty Pharmacy
9. Valbenazine API Market, by Dosage Strength
9.1. Introduction
9.2. 40 Mg
9.3. 80 Mg
9.2. 40 Mg
9.3. 80 Mg
10. Valbenazine API Market, by Treatment Setting
10.1. Introduction
10.2. Inpatient
10.3. Outpatient
10.2. Inpatient
10.3. Outpatient
11. Valbenazine API Market, by Patient Age Group
11.1. Introduction
11.2. Adults 18 To 64
11.2.1. 18 To 40
11.2.2. 41 To 64
11.3. Elderly 65 Plus
11.2. Adults 18 To 64
11.2.1. 18 To 40
11.2.2. 41 To 64
11.3. Elderly 65 Plus
12. Valbenazine API Market, by Gender
12.1. Introduction
12.2. Female
12.3. Male
12.2. Female
12.3. Male
13. Americas Valbenazine API Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Valbenazine API Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Valbenazine API Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Lonza Group AG
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. Catalent, Inc.
16.3.4. WuXi AppTec Co., Ltd.
16.3.5. Recipharm AB
16.3.6. Jubilant Life Sciences Limited
16.3.7. Cambrex Corporation
16.3.8. Siegfried Holding AG
16.3.9. Piramal Pharma Limited
16.3.10. Almac Group Limited
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Lonza Group AG
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. Catalent, Inc.
16.3.4. WuXi AppTec Co., Ltd.
16.3.5. Recipharm AB
16.3.6. Jubilant Life Sciences Limited
16.3.7. Cambrex Corporation
16.3.8. Siegfried Holding AG
16.3.9. Piramal Pharma Limited
16.3.10. Almac Group Limited
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. VALBENAZINE API MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VALBENAZINE API MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VALBENAZINE API MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VALBENAZINE API MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VALBENAZINE API MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VALBENAZINE API MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VALBENAZINE API MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VALBENAZINE API MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VALBENAZINE API MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VALBENAZINE API MARKET: RESEARCHAI
FIGURE 26. VALBENAZINE API MARKET: RESEARCHSTATISTICS
FIGURE 27. VALBENAZINE API MARKET: RESEARCHCONTACTS
FIGURE 28. VALBENAZINE API MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL VALBENAZINE API MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VALBENAZINE API MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VALBENAZINE API MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VALBENAZINE API MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VALBENAZINE API MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VALBENAZINE API MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VALBENAZINE API MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VALBENAZINE API MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VALBENAZINE API MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VALBENAZINE API MARKET: RESEARCHAI
FIGURE 26. VALBENAZINE API MARKET: RESEARCHSTATISTICS
FIGURE 27. VALBENAZINE API MARKET: RESEARCHCONTACTS
FIGURE 28. VALBENAZINE API MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VALBENAZINE API MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VALBENAZINE API MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VALBENAZINE API MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VALBENAZINE API MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VALBENAZINE API MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VALBENAZINE API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VALBENAZINE API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VALBENAZINE API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VALBENAZINE API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VALBENAZINE API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VALBENAZINE API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VALBENAZINE API MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VALBENAZINE API MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VALBENAZINE API MARKET SIZE, BY 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VALBENAZINE API MARKET SIZE, BY 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VALBENAZINE API MARKET SIZE, BY 80 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VALBENAZINE API MARKET SIZE, BY 80 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VALBENAZINE API MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VALBENAZINE API MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VALBENAZINE API MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VALBENAZINE API MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VALBENAZINE API MARKET SIZE, BY 18 TO 40, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VALBENAZINE API MARKET SIZE, BY 18 TO 40, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VALBENAZINE API MARKET SIZE, BY 41 TO 64, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VALBENAZINE API MARKET SIZE, BY 41 TO 64, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VALBENAZINE API MARKET SIZE, BY ELDERLY 65 PLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VALBENAZINE API MARKET SIZE, BY ELDERLY 65 PLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VALBENAZINE API MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VALBENAZINE API MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VALBENAZINE API MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VALBENAZINE API MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS VALBENAZINE API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS VALBENAZINE API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES VALBENAZINE API MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES VALBENAZINE API MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 75. CANADA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. CANADA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. CANADA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 78. CANADA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 79. CANADA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 80. CANADA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 81. CANADA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 82. CANADA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 83. CANADA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 84. CANADA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 85. CANADA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 86. CANADA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 87. MEXICO VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. MEXICO VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. MEXICO VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 90. MEXICO VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 91. MEXICO VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 92. MEXICO VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 93. MEXICO VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 94. MEXICO VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 95. MEXICO VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 96. MEXICO VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 97. MEXICO VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 98. MEXICO VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 149. GERMANY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. GERMANY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. GERMANY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 152. GERMANY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 153. GERMANY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 154. GERMANY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 155. GERMANY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 156. GERMANY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 157. GERMANY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 158. GERMANY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 159. GERMANY VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 160. GERMANY VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 161. FRANCE VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. FRANCE VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. FRANCE VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. FRANCE VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. FRANCE VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 166. FRANCE VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 167. FRANCE VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. FRANCE VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. FRANCE VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 170. FRANCE VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 171. FRANCE VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 172. FRANCE VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 173. RUSSIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. RUSSIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 185. ITALY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ITALY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ITALY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. ITALY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. ITALY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 190. ITALY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 191. ITALY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 192. ITALY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 193. ITALY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 194. ITALY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 195. ITALY VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 196. ITALY VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 197. SPAIN VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. SPAIN VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. SPAIN VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 200. SPAIN VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 201. SPAIN VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 202. SPAIN VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 203. SPAIN VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 204. SPAIN VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 205. SPAIN VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 206. SPAIN VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 207. SPAIN VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 208. SPAIN VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 224. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 236. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 245. DENMARK VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. DENMARK VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. DENMARK VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 248. DENMARK VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 249. DENMARK VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 250. DENMARK VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 251. DENMARK VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 252. DENMARK VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 253. DENMARK VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 254. DENMARK VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 255. DENMARK VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 256. DENMARK VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 257. NETHERLANDS VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. NETHERLANDS VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. NETHERLANDS VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 260. NETHERLANDS VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 269. QATAR VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. QATAR VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. QATAR VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 272. QATAR VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 273. QATAR VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 274. QATAR VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 275. QATAR VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 276. QATAR VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 277. QATAR VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 278. QATAR VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 279. QATAR VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 280. QATAR VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 281. FINLAND VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. FINLAND VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. FINLAND VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 284. FINLAND VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 285. FINLAND VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 286. FINLAND VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 287. FINLAND VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 288. FINLAND VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 289. FINLAND VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 290. FINLAND VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 291. FINLAND VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 292. FINLAND VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 293. SWEDEN VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. SWEDEN VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SWEDEN VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 296. SWEDEN VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 305. NIGERIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. NIGERIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. NIGERIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 308. NIGERIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 317. EGYPT VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. EGYPT VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. EGYPT VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 320. EGYPT VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 321. EGYPT VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 322. EGYPT VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 323. EGYPT VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 324. EGYPT VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 325. EGYPT VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 326. EGYPT VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 327. EGYPT VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 328. EGYPT VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 329. TURKEY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. TURKEY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. TURKEY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 332. TURKEY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 333. TURKEY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 334. TURKEY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 335. TURKEY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 336. TURKEY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 337. TURKEY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 338. TURKEY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 339. TURKEY VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 340. TURKEY VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 341. ISRAEL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. ISRAEL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. ISRAEL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 344. ISRAEL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 345. ISRAEL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 346. ISRAEL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 347. ISRAEL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 348. ISRAEL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 349. ISRAEL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 350. ISRAEL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 351. ISRAEL VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 352. I
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VALBENAZINE API MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VALBENAZINE API MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VALBENAZINE API MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VALBENAZINE API MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VALBENAZINE API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VALBENAZINE API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VALBENAZINE API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VALBENAZINE API MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VALBENAZINE API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VALBENAZINE API MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VALBENAZINE API MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VALBENAZINE API MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VALBENAZINE API MARKET SIZE, BY 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VALBENAZINE API MARKET SIZE, BY 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VALBENAZINE API MARKET SIZE, BY 80 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VALBENAZINE API MARKET SIZE, BY 80 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VALBENAZINE API MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VALBENAZINE API MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VALBENAZINE API MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VALBENAZINE API MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VALBENAZINE API MARKET SIZE, BY 18 TO 40, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VALBENAZINE API MARKET SIZE, BY 18 TO 40, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VALBENAZINE API MARKET SIZE, BY 41 TO 64, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VALBENAZINE API MARKET SIZE, BY 41 TO 64, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VALBENAZINE API MARKET SIZE, BY ELDERLY 65 PLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VALBENAZINE API MARKET SIZE, BY ELDERLY 65 PLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VALBENAZINE API MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VALBENAZINE API MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VALBENAZINE API MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VALBENAZINE API MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS VALBENAZINE API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS VALBENAZINE API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES VALBENAZINE API MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES VALBENAZINE API MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 75. CANADA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. CANADA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. CANADA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 78. CANADA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 79. CANADA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 80. CANADA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 81. CANADA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 82. CANADA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 83. CANADA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 84. CANADA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 85. CANADA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 86. CANADA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 87. MEXICO VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. MEXICO VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. MEXICO VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 90. MEXICO VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 91. MEXICO VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 92. MEXICO VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 93. MEXICO VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 94. MEXICO VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 95. MEXICO VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 96. MEXICO VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 97. MEXICO VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 98. MEXICO VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA VALBENAZINE API MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 149. GERMANY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. GERMANY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. GERMANY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 152. GERMANY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 153. GERMANY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 154. GERMANY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 155. GERMANY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 156. GERMANY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 157. GERMANY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 158. GERMANY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 159. GERMANY VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 160. GERMANY VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 161. FRANCE VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. FRANCE VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. FRANCE VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 164. FRANCE VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 165. FRANCE VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 166. FRANCE VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 167. FRANCE VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. FRANCE VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. FRANCE VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 170. FRANCE VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 171. FRANCE VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 172. FRANCE VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 173. RUSSIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. RUSSIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. RUSSIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 176. RUSSIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 185. ITALY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ITALY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ITALY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. ITALY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. ITALY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 190. ITALY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 191. ITALY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 192. ITALY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 193. ITALY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 194. ITALY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 195. ITALY VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 196. ITALY VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 197. SPAIN VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. SPAIN VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. SPAIN VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 200. SPAIN VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 201. SPAIN VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 202. SPAIN VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 203. SPAIN VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 204. SPAIN VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 205. SPAIN VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 206. SPAIN VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 207. SPAIN VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 208. SPAIN VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 224. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 236. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 245. DENMARK VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. DENMARK VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. DENMARK VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 248. DENMARK VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 249. DENMARK VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 250. DENMARK VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 251. DENMARK VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 252. DENMARK VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 253. DENMARK VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 254. DENMARK VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 255. DENMARK VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 256. DENMARK VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 257. NETHERLANDS VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. NETHERLANDS VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. NETHERLANDS VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 260. NETHERLANDS VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 269. QATAR VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. QATAR VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. QATAR VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 272. QATAR VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 273. QATAR VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 274. QATAR VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 275. QATAR VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 276. QATAR VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 277. QATAR VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 278. QATAR VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 279. QATAR VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 280. QATAR VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 281. FINLAND VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. FINLAND VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. FINLAND VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 284. FINLAND VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 285. FINLAND VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 286. FINLAND VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 287. FINLAND VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 288. FINLAND VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 289. FINLAND VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 290. FINLAND VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 291. FINLAND VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 292. FINLAND VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 293. SWEDEN VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. SWEDEN VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SWEDEN VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 296. SWEDEN VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 305. NIGERIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. NIGERIA VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. NIGERIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 308. NIGERIA VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 317. EGYPT VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. EGYPT VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. EGYPT VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 320. EGYPT VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 321. EGYPT VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 322. EGYPT VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 323. EGYPT VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 324. EGYPT VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 325. EGYPT VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 326. EGYPT VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 327. EGYPT VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 328. EGYPT VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 329. TURKEY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. TURKEY VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. TURKEY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 332. TURKEY VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 333. TURKEY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 334. TURKEY VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 335. TURKEY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 336. TURKEY VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 337. TURKEY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 338. TURKEY VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 339. TURKEY VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 340. TURKEY VALBENAZINE API MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 341. ISRAEL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. ISRAEL VALBENAZINE API MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. ISRAEL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 344. ISRAEL VALBENAZINE API MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 345. ISRAEL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 346. ISRAEL VALBENAZINE API MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 347. ISRAEL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 348. ISRAEL VALBENAZINE API MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 349. ISRAEL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2018-2024 (USD MILLION)
TABLE 350. ISRAEL VALBENAZINE API MARKET SIZE, BY ADULTS 18 TO 64, 2025-2030 (USD MILLION)
TABLE 351. ISRAEL VALBENAZINE API MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 352. I
Samples
LOADING...
Companies Mentioned
The companies profiled in this Valbenazine API market report include:- Lonza Group AG
- Thermo Fisher Scientific Inc.
- Catalent, Inc.
- WuXi AppTec Co., Ltd.
- Recipharm AB
- Jubilant Life Sciences Limited
- Cambrex Corporation
- Siegfried Holding AG
- Piramal Pharma Limited
- Almac Group Limited
